JP2015071583A5 - - Google Patents

Download PDF

Info

Publication number
JP2015071583A5
JP2015071583A5 JP2014060235A JP2014060235A JP2015071583A5 JP 2015071583 A5 JP2015071583 A5 JP 2015071583A5 JP 2014060235 A JP2014060235 A JP 2014060235A JP 2014060235 A JP2014060235 A JP 2014060235A JP 2015071583 A5 JP2015071583 A5 JP 2015071583A5
Authority
JP
Japan
Prior art keywords
active ingredient
soybean lecithin
food
atrodin
muscle atrophy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014060235A
Other languages
English (en)
Japanese (ja)
Other versions
JP6374682B2 (ja
JP2015071583A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014060235A priority Critical patent/JP6374682B2/ja
Priority claimed from JP2014060235A external-priority patent/JP6374682B2/ja
Publication of JP2015071583A publication Critical patent/JP2015071583A/ja
Publication of JP2015071583A5 publication Critical patent/JP2015071583A5/ja
Application granted granted Critical
Publication of JP6374682B2 publication Critical patent/JP6374682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014060235A 2013-09-09 2014-03-24 筋萎縮抑制剤 Active JP6374682B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014060235A JP6374682B2 (ja) 2013-09-09 2014-03-24 筋萎縮抑制剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013185976 2013-09-09
JP2013185976 2013-09-09
JP2014060235A JP6374682B2 (ja) 2013-09-09 2014-03-24 筋萎縮抑制剤

Publications (3)

Publication Number Publication Date
JP2015071583A JP2015071583A (ja) 2015-04-16
JP2015071583A5 true JP2015071583A5 (cg-RX-API-DMAC10.html) 2017-03-02
JP6374682B2 JP6374682B2 (ja) 2018-08-15

Family

ID=53014251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014060235A Active JP6374682B2 (ja) 2013-09-09 2014-03-24 筋萎縮抑制剤

Country Status (1)

Country Link
JP (1) JP6374682B2 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7824621B2 (ja) * 2021-04-13 2026-03-05 国立大学法人神戸大学 筋萎縮抑制用組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503482B1 (en) * 1991-06-10 2003-01-07 Schering Corporation Non-chlorofluorocarbon aerosol formulations
JP4739161B2 (ja) * 2005-10-26 2011-08-03 花王株式会社 持久力向上剤
JP2008013473A (ja) * 2006-07-05 2008-01-24 Kao Corp 筋機能低下抑制剤
US8877239B2 (en) * 2010-08-12 2014-11-04 Nutritional Therapeutics, Inc. Lipid supplements for maintaining health and treatment of acute and chronic disorders
JP5922863B2 (ja) * 2010-02-03 2016-05-24 花王株式会社 運動機能改善剤
ES2614115T3 (es) * 2010-03-24 2017-05-29 Medesis Pharma Sistema de micelas inversas que comprenden ácidos nucleicos y su uso

Similar Documents

Publication Publication Date Title
PT3565550T (pt) Composições farmacêuticas compreendendo meloxicam e rizatriptano
PL3621621T3 (pl) Kompozycje farmaceutyczne zawierające meloksykam
IL247836B (en) 1, 3-benzodioxole derivatives, preparations containing them and their uses
IL259138B (en) Preparations containing bacterial strains
CA3278634A1 (en) Pharmaceutical compositions comprising meloxicam
IL269803A (en) Implications of 6-pyrimidine-isoindole as an ERK1/2 inhibitor
EP3371152A4 (en) COMPOSITIONS WITH AN INHIBITOR OF LYSINE-SPECIFIC DEMETHYLASE-1
IL252828A0 (en) Piperidine derivative compounds suppressing hdac1/2 preparations containing them and their uses
EP3193854A4 (en) Eutectic formulations of cyclobenzaprine hydrochloride
EP3231436A4 (en) Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient
DK3103453T3 (da) Medicinsk sammensætning omfattende heterocyklisk diamino-carboxamidforbindelse som aktiv bestanddel
IL248773B (en) History -6,1-Naphthyridine-5,4-Dione and pharmaceutical preparations containing them
IL266833B (en) Organ preservation preparations
ZA201804203B (en) Pharmaceutical compositions comprising phenylaminopyrimidine derivative
IL304109A (en) Pharmaceutical preparations containing spinamide
MA49837A (fr) Compositions pharmaceutiques
EP3199530A4 (en) Benzofuran analogue as ns4b inhibitor
EP3216452A4 (en) Composition for preventing or treating mucositis comprising necrox as effective ingredient
EP3423041A4 (en) PHARMACEUTICAL COMPOSITIONS
EP3528818A4 (en) PHARMACEUTICAL COMPOSITIONS
ZA202003079B (en) Pharmaceutical compositions comprising safinamide
EP3120848A4 (en) Therapeutic/preventive agent containing coumarin derivative as active ingredient
LT3558261T (lt) Farmacinės kompozicijos, apimančios safinamidą
MA49625A (fr) Compositions pharmaceutiques
JP2015071584A5 (cg-RX-API-DMAC10.html)